Patents by Inventor Gregory M. Hayes

Gregory M. Hayes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-CD39 antibodies and uses thereof
    Patent number: 10556959
    Abstract: The present disclosure relates generally to anti-CD39 antibodies, including antibody-drug conjugates comprising the antibodies, and methods of their use.
    Type: Grant
    Filed: November 6, 2015
    Date of Patent: February 11, 2020
    Assignee: Xencor, Inc.
    Inventors: Guoqing Chen, Gregory M. Hayes, Jan-Willem Theunissen, Edward Thein H. Van Der Horst, Leonard G. Presta
  • ANTI-CD39 ANTIBODIES AND USES THEREOF
    Publication number: 20170335007
    Abstract: The present disclosure relates generally to anti-CD39 antibodies, including antibody-drug conjugates comprising the antibodies, and methods of their use.
    Type: Application
    Filed: November 6, 2015
    Publication date: November 23, 2017
    Inventors: Guoqing Chen, Gregory M. Hayes, Jan-Willem Theunissen, Edward Thein H. Van Der Horst, Leonard G. Presta
  • Expression Of Soluble Viral Fusion Glycoproteins In Mammalian Cells
    Publication number: 20140024076
    Abstract: The technology relates in part to production (i.e., expression) of recombinant viral fusion glycoproteins and nucleic acids that encode such viral fusion glycoproteins. In some embodiments, human respiratory syncytial virus fusion protein (RSV-F) and human parainfluenza virus 3 fusion protein (hPIV3-F) are expressed.
    Type: Application
    Filed: January 27, 2012
    Publication date: January 23, 2014
    Applicant: MEDIMMUNE, LLC.
    Inventors: Roderick Tang, Gregory M. Hayes, Heather Lawlor, Peifeng Chen, Yi Liu
  • IDENTIFYING DUCT CANCERS
    Publication number: 20100093005
    Abstract: This document relates to methods and materials involved in identifying mammals that are likely to have duct cancer. For example, this document provides methods and materials related to using the presence of a variant form of the secretin receptor in a mammal's blood to identify the mammal (e.g., human) as being likely to have duct cancer.
    Type: Application
    Filed: November 12, 2007
    Publication date: April 15, 2010
    Inventors: Laurence J. Miller, Gregory M. Hayes